- Centene anticipates its adjusted earnings per share (EPS) for 2025 to be above $7.25, surpassing the estimated $7.11.
- Revenue is forecasted to range between $166.5 billion and $169.5 billion, with an estimate of $168.15 billion.
- The health benefits ratio is expected to be between 88.4% and 89%, compared to the estimate of 88.1%.
- Premium and Service Revenues for 2025 are projected to be between $154.0 billion and $156.0 billion.
- For the current year, Centene maintains its adjusted EPS forecast above $6.80, with an estimate of $6.83.
- The health benefits ratio for the current year is anticipated to be between 88.3% and 88.5%, against an estimate of 88%.
- Premium and Service Revenues for the current year are predicted to range from $143.5 billion to $144.5 billion.
- The company has a mixed analyst rating with 11 buys, 9 holds, and 1 sell recommendation.
Centene Corp on Smartkarma
Centene Corp has received positive analyst coverage on Smartkarma from Baptista Research. In their report titled “Centene Corporation: Operational Efficiency & AI Utilization Driving Our Optimism! – Major Drivers”, the analysts highlighted the company’s third-quarter financial results for 2024. Despite showcasing both strengths and challenges within its operations, Centene exceeded expectations with an adjusted diluted EPS of $1.62. This outperformance was attributed to the realization of tax benefits earlier than projected, contributing to a positive outlook.
Furthermore, in another report by Baptista Research titled “Centene Corporation: Medicaid Managed Care Expansion and Optimization! – Major Drivers”, Centene’s strong financial performance in the first quarter of the year was emphasized. The company exceeded expected adjusted earnings per share at $2.26, leading to an upward revision in their full-year 2024 forecast to over $6.80 per share. These results not only demonstrate operational efficiency but also outline a comprehensive view of Centene’s progress, encompassing areas of strength and ongoing challenges.
A look at Centene Corp Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 4 | |
Dividend | 1 | |
Growth | 5 | |
Resilience | 3 | |
Momentum | 2 | |
OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Centene Corp is well-positioned for long-term growth and value appreciation. With a top score of 5 in Growth, the company is expected to expand and increase its market presence. Additionally, a solid score of 4 in Value indicates that Centene Corp may be currently undervalued compared to its potential, offering an attractive investment opportunity.
While Centene Corp shows strength in growth and value, its Dividend score of 1 suggests that it may not be a strong choice for income-seeking investors. Combining a moderate level of Resilience at 3 and a lower Momentum score of 2, Centene Corp may experience some volatility but could withstand market challenges reasonably well in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars